Immune index: a gene and cell prognostic signature for immunotherapy response prediction in hepatocellular carcinoma
#anti-human CD8a (RPA-T8) from BioGems; # anti-human CD56 from BioGems XiuliangCuia1LuHanbc1LongjiuCuid1GongboFuaErdongLiuaDuoweiWangeBinSongfYongxiangZhangbcWenxiaZhoubcHongyangWangaJingFua https://doi.org/10.1016/j.phrs.2022.106583 Abstract The heterogeneity of tumor immune microenvironment (TIME) plays important roles in the development and immunotherapy response of hepatocellular carcinoma (HCC). Using machine learning algorithms, we introduced the immune index (IMI), a prognostic model based on the HCC immune landscape. We found that …